International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Carbidopa 1.25-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2007 - Pediatric Patients
View All Articles in Issue

Page(s): 70

Download in electronic PDF format for $75

Abstract: A formulation for preparing Carbidopa 1.25-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: FORMULATIONS, CARBIDOPA, LIQUID PREPARATIONS, CHILDREN, EYE DISORDERS, VISION DISORDERS, DOPAMINE AGONIST, AMBLYOPIA, PARKINSONISM, PARKINSON'S DISEASE, ELDERLY

Related Categories: FORMULATIONS, GERIATRICS, OPHTHALMICS, PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Carbidopa 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 70
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2021 Pg. 145
Levodopa and Carbidopa Rectal Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 149
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
The Treatment of Canine Atopic Disease Davidson Gigi S	May/Jun 2002 Pg. 210-215
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn	Sep/Oct 2009 Pg. 386-389
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2002 Pg. 202
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Allen Loyd V Jr	Sep/Oct 2018 Pg. 410
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Glasnapp Andrew, Schaefer Erin	Jul/Aug 2000 Pg. 276-279
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2003 Pg. 304
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	May/Jun 2007 Pg. 220-225
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Return to Top